The University of Texas MD Anderson Cancer Center
ORCID: 0000-0002-5042-7366Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 9 papers. Top paper: “Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit”.
Sahira Farooq, Macartney Welborn, Rodabe N. Amaria, Susan Y. Chon, Adi Diab +13 more
Clara Curiel‐Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre‐Ghiso +31 more
Cristián Navarrete‐Dechent, Michael A. Marchetti, Veronica Rotemberg, Zoé Apalla, Giuseppe Argenziano +36 more
Lillian R. Morris, Kehe Zhang, Emelie E Nelson, Tiffaney Tran, Marcita Galindez +8 more
Brooke Bartley, Stephanie J. Zhang, Madison M. Taylor, Karl Schrader, Kehe Zhang +5 more
Ming‐Lang Zhao, Pamela Schroeder, Zhi Liu, Luis A. Diaz, Ning Li +2 more
Reece Moore, Jing He, Clark R. Andersen, Maria C. Swartz, Kelly C. Nelson +2 more
Tiffaney Tran, Russell G. Witt, Kelly C. Nelson, Maleka Najmi
Lillian K. Morris, Emelie E Nelson, Adewole S. Adamson, Zhigang Duan, Hui Zhao +7 more